Search
Autologous Non-Hematopoietic Peripheral Blood Stem Cells
go.drugbank.com/drugs/DB15867InvestigationalAutologous non-hematopoietic peripheral blood stem cells have been created into a formulation for use in a clinical trial (NCT04473170) by the Abu Dhabi Stem Cells Center. … The cells have the characterizations of CD90+, CD133+, Oct-4+, CD45-, and CD71-.[L16363]
Methylisothiazolinone
go.drugbank.com/drugs/DB15884InvestigationalSynonyms: 2-Methyl-4-isothiazolin-3-one, 2-Methyl-4-isothiazoline-3-oneCategories: Compounds used in a research, industrial, or household setting, Heterocyclic Compounds, 1-RingXAV-19
go.drugbank.com/drugs/DB15895InvestigationalAs of July, 2020, the company is conducting a Phase 2 randomized clinical trial to define dosing safety and efficacy of XAV-19 (NCT04453384). … However, rather than using human plasma, XAV-19 is a heterologous swine glyco-humanized polyclonal antibody that targets the spike protein of SARS-CoV-2[L16553,L16558].
Fenchone
go.drugbank.com/drugs/DB15918InvestigationalCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2A6 SubstratesCarbaryl
go.drugbank.com/drugs/DB15930InvestigationalCategories: Compounds used in a research, industrial, or household settingProducts: PIOREL LOCION DE CARBARILOImdevimab
go.drugbank.com/drugs/DB15940ApprovedInvestigational[L23539] This drug is a combination of antibodies derived from humanized VelocImmune® mice in addition to blood samples from patients who have recovered from COVID-19. … Imdevimab is a monoclonal antibody combined with [casirivimab] in Regeneron's antibody cocktail known as REGEN-COV2 for the treatment of COVID-19.
Thiamine disulfide
go.drugbank.com/drugs/DB15958InvestigationalMixtures: Arca-Be DrageesCategories: Heterocyclic Compounds, 1-Ring